Compare NRIX & GRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRIX | GRBK |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | United States | United States |
| Employees | N/A | 620 |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2020 | 2006 |
| Metric | NRIX | GRBK |
|---|---|---|
| Price | $14.76 | $59.92 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $33.50 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 270.8K |
| Earning Date | 10-12-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 3.26 | ★ 4.44 |
| Revenue | $76,987,000.00 | ★ $2,098,471,000.00 |
| Revenue This Year | $786.93 | N/A |
| Revenue Next Year | N/A | $0.16 |
| P/E Ratio | ★ $4.52 | $13.50 |
| Revenue Growth | ★ 99.31 | N/A |
| 52 Week Low | $12.61 | $59.12 |
| 52 Week High | $28.23 | $83.18 |
| Indicator | NRIX | GRBK |
|---|---|---|
| Relative Strength Index (RSI) | 25.08 | 40.42 |
| Support Level | $14.65 | N/A |
| Resistance Level | $17.47 | $74.40 |
| Average True Range (ATR) | 1.22 | 2.40 |
| MACD | -0.77 | -0.25 |
| Stochastic Oscillator | 0.23 | 1.31 |
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment, which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgages and title.